Nexstim Plc Overview
Pro stress-test →Nexstim is a Finnish medical technology company specializing in navigated transcranial magnetic stimulation (nTMS), a non-invasive brain stimulation technology using electromagnetic pulses to target specific brain regions. The company develops two primary product platforms: the NBS System for pre-surgical brain mapping and the NBT System for treating major depressive disorder and chronic neuropathic pain.
Strategic Profile
Pro stress-test →Nexstim differentiates through 3D navigation technology enabling personalized, targeted brain stimulation. The company has established market presence with systems in over 100 clinical facilities globally, with North America representing the majority of revenue. Strategic partnerships, including collaboration with Brainlab and Sinaptica Therapeutics, strengthen product development and commercialization capabilities.
Competitive Landscape
Pro stress-test →Nexstim competes with established TMS providers including NeuroStar (Magventure), Magstim, and MagVenture. Competitive advantages include advanced navigation technology, presurgical mapping capabilities, and expanding therapeutic pipeline. Primary differentiation is proprietary 3D navigation for personalized targeting, though larger competitors have greater scale and clinical evidence.
Industry Context
Nexstim Plc operates in Medical Device / Neurotechnology / Brain Stimulation.
Key facts
Founded: 2000 · Headquarters: Helsinki, Finland · Employees: 40 · Revenue: $10.2M · Market cap: $70.3M-$110.4M